Product Information

PRIFTIN 150 MG TABLET is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $4.8249 per EA under NDC 00088210224. Its NADAC has been published 353 times since Nov 20, 2019.

FDA first approved this application on Jun 22, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PRIFTIN 150 MG TABLET

rifapentine
$4.8249per EA

Strength

150 mg/1

NDC

00088210224

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

RIFAPENTINE

Approval Type

New Drug (NDA)

FDA Application

NDA021024

FDA Approved

6/22/1998

TE Code

AB

On Market Since

2/8/2017

Pharmacological Classes

Rifamycin Antimycobacterial
Rifamycins

Price Statistics

The NADAC for PRIFTIN 150 MG TABLET has been published 353 times since Nov 20, 2019, and over the history we have for it it has risen 32.3%. The table below summarizes its recorded NADAC range and movement.

Current price$4.8249 per EA
All-time high$4.8468 (May 13, 2026)
All-time low$3.6468 (Nov 20, 2019)
52-week high$4.8468
52-week low$4.7508
Median price$4.4322
Average price$4.3592
Largest weekly change+5.4% (Jan 15, 2020)
Weeks tracked353
Tracking sinceNov 20, 2019

Price History

1W

-0.0%

1M

-0.0%

3M

-0.2%

6M

-0.5%

1Y

+1.5%

3Y

+8.9%

5Y

+19.4%

All

+32.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the rifapentine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of PRIFTIN 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PRIFTIN 150 MG TABLET, manufactured by Sanofi-Aventis U.S. LLC, is $4.8249 per EA (NDC 00088210224), effective Aug 19, 2026.

How has the price of PRIFTIN 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for PRIFTIN 150 MG TABLET has risen 32.3%. It has been tracked across 353 weekly CMS publications since Nov 20, 2019.

What are the highest and lowest recorded NADAC prices for PRIFTIN 150 MG TABLET?

Since Nov 20, 2019, the NADAC for PRIFTIN 150 MG TABLET has ranged from a low of $3.6468 (Nov 20, 2019) to a high of $4.8468 (May 13, 2026), with a median of $4.4322 per EA.

Are there cheaper alternatives to PRIFTIN 150 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PRIFTIN 150 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PRIFTIN 150 MG TABLET?

PRIFTIN 150 MG TABLET (NDC 00088210224) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.